LeMaitre Vascular Stock Forecast
NASDAQ: LMATHealthcareMedical Instruments & SuppliesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
LMAT analyst consensus
Consensus (8 analysts)
buy
Avg. price target
$107.00+34.35%
- Strong buy 2
- Buy 2
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering LeMaitre Vascular (2026-10-09), 4 rate the stock a buy or strong buy, 4 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $107.00, with a high estimate of $132.00 and a low estimate of $81.00. The average target implies upside of 34.4% from the current price of $79.64.
The spread between the highest and lowest targets is 63.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LMAT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 25% |
| Buy | 2 | 25% |
| Hold | 4 | 50% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $81.00 | +1.71% |
| Average target | $107.00 | +34.35% |
| High target | $132.00 | +65.75% |